HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karen So Selected Research

human TGFB3 protein

7/2011Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial.
11/2010Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trial.
1/2010Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
4/2009Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karen So Research Topics

Disease

8Neoplasms (Cancer)
10/2022 - 06/2015
7Wounds and Injuries (Trauma)
05/2014 - 04/2009
6Cicatrix (Scar)
05/2014 - 04/2009
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 09/2017
3Plexiform Neurofibroma
01/2022 - 01/2021
3Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2022 - 01/2021
2Breast Neoplasms (Breast Cancer)
12/2018 - 06/2015
1Thyroid Neoplasms (Thyroid Cancer)
10/2022
1Dermatitis
10/2022
1Neoplasm Metastasis (Metastasis)
01/2020
1Disease Progression
01/2020
1Thrombocytopenia (Thrombopenia)
09/2017
1Epistaxis (Nosebleed)
09/2017
1Lethargy
09/2017
1Febrile Neutropenia
09/2017
1Chronic Kidney Failure (Chronic Renal Failure)
01/2017
1Liver Diseases (Liver Disease)
01/2017
1Ovarian Neoplasms (Ovarian Cancer)
10/2016
1Inflammation (Inflammations)
05/2013
1Erythema
04/2009

Drug/Important Bio-Agent (IBA)

8AZD 6244IBA
10/2022 - 11/2016
5osimertinibIBA
01/2020 - 01/2018
4human TGFB3 proteinIBA
07/2011 - 04/2009
3ErbB Receptors (EGF Receptor)IBA
01/2020 - 01/2018
3Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2018
3olaparibIBA
10/2016 - 06/2015
3CytokinesIBA
05/2013 - 01/2010
2Pharmaceutical PreparationsIBA
10/2022 - 01/2020
2Simvastatin (Zocor)FDA LinkGeneric
01/2020 - 12/2018
2Phosphotransferases (Kinase)IBA
01/2020 - 11/2016
2Cytochrome P-450 CYP3AIBA
12/2018 - 10/2016
2Itraconazole (Sporanox)FDA LinkGeneric
01/2018 - 10/2016
2Rifampin (Rifampicin)FDA LinkGeneric
01/2018 - 10/2016
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2016 - 06/2015
2Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2015 - 06/2015
2Interleukin-10 (Interleukin 10)IBA
05/2014 - 05/2013
2CollagenIBA
07/2011 - 04/2009
2Transforming Growth Factor beta (TGF-beta)IBA
11/2010 - 01/2010
1IodineIBA
10/2022
1MAP Kinase Kinase 1IBA
01/2022
1adavosertibIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
12/2018
1Rosuvastatin Calcium (Crestor)FDA Link
12/2018
1Omeprazole (Prilosec)FDA LinkGeneric
01/2018
1Cytochrome P-450 CYP3A InhibitorsIBA
01/2018
1Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
11/2017
1Pemetrexed (MTA)FDA Link
09/2017
1PlatinumIBA
09/2017
1Carboplatin (JM8)FDA LinkGeneric
09/2017
1Cisplatin (Platino)FDA LinkGeneric
09/2017
1GemcitabineFDA Link
09/2017
1MitogensIBA
11/2016
1EnzymesIBA
10/2016
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
10/2016
1Capsules (Microcapsules)IBA
06/2015
1Therapeutic UsesIBA
05/2014
1Interleukin-4 (Interleukin 4)IBA
05/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2011
1Transforming Growth Factor beta3 (TGF beta 3)IBA
04/2009

Therapy/Procedure

2Reoperation
07/2011 - 01/2010
2Therapeutics
01/2010 - 04/2009
1Aftercare (After-Treatment)
12/2018
1Drug Therapy (Chemotherapy)
09/2017
1Renal Dialysis (Hemodialysis)
01/2017
1Intradermal Injections
11/2010
1Injections
11/2010
1Electrodes (Electrode)
03/2010
1Occlusive Dressings (Occlusive Dressing)
03/2010